MDM2 and lung cancer: The SNP285C allele diminish Sp1 binding to the MDM2 promoter, and has been found to be associated with reduced risk for breast, ovarian and endometrial cancer [18, 20–22], but was not associated with prostate or lung cancer risk [20, 21, 23].